Associations between toll-like receptors and interleukin-4 in the lungs of patients with tuberculosis

被引:29
作者
Fenhalls, G
Squires, GR
Stevens-Muller, L
Bezuidenhout, J
Amphlett, G
Duncan, K
Lukey, PT
机构
[1] GlaxoSmithKline R&D, Dis Dev World, Stevenage SG1 2NY, Herts, England
[2] GlaxoSmithKline R&D, Asthma Cell Biol, Stevenage SG1 2NY, Herts, England
[3] GlaxoSmithKline R&D, Stat Sci, Stevenage SG1 2NY, Herts, England
[4] Univ Stellenbosch, MRC, Ctr Mol & Cellular Biol, Cape Town, South Africa
[5] Univ Stellenbosch, Dept Biochem Med, Cape Town, South Africa
[6] Univ Stellenbosch, Dept Anat Pathol, Cape Town, South Africa
关键词
D O I
10.1165/rcmb.2002-0163OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) are implicated in the intracellular killing of Mycobacterium tuberculosis, and their expression is modulated by interieukin-4 (IL-4) in vitro. Our aim was to examine the expression of TLRs at the site of pathology in tuberculous lung granulomas and to explore the effect of the immune response on TLR expression. Immunohistochemistry was performed on lung granulomas from nine patients with tuberculosis undergoing lobectomy for haemoptysis. All nine patients expressed all of the TLRs studied (TLRs 1-5 and 9), whereas only five out of the nine patients had any granulomas positive for IL-4. Statistical analysis of TLR and cytokine staining patterns in 183 individual granulomas from the nine patients revealed significant associations between pairs of receptors and IL-4. A positive association between TLR2 and TLR4 (P < 0.0001) and a negative association between TLR2 and IL-4 (P < 0.0001) was observed. The associations between TLRs 1, 5, and 9 were significantly different in IL-4-negative compared with IL-4-positive patients. In conclusion, TLRs are expressed by various cell types in the human tuberculous lung, and their expression patterns are reflected by differences in the immune response.
引用
收藏
页码:28 / 38
页数:11
相关论文
共 43 条
[1]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[2]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[3]   Cooperation of toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein:: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling [J].
Bulut, Y ;
Faure, E ;
Thomas, L ;
Equils, O ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :987-994
[4]  
Canetti G, 1955, TUBERCLE BACILLUS PU
[5]   Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease [J].
Cario, E ;
Podolsky, DK .
INFECTION AND IMMUNITY, 2000, 68 (12) :7010-7017
[6]   Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells [J].
Chuang, TH ;
Ulevitch, RJ .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1518 (1-2) :157-161
[7]   Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli [J].
Converse, PJ ;
Dannenberg, AM ;
Estep, JE ;
Sugisaki, K ;
Abe, Y ;
Schofield, BH ;
Pitt, MLM .
INFECTION AND IMMUNITY, 1996, 64 (11) :4776-4787
[8]  
DASILVA CJ, 2002, J BIOL CHEM, V277, P1845, DOI [DOI 10.1074/JBC.M109910200, 10.1074/jbc.M109910200]
[9]   Granulomatous inflammation and the transmission of infection: schistosomiasis - and TB too? [J].
Doenhoff, MJ .
IMMUNOLOGY TODAY, 1998, 19 (10) :462-467
[10]   Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination [J].
Elias, D ;
Wolday, D ;
Akuffo, H ;
Petros, B ;
Bronner, U ;
Britton, S .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (02) :219-225